featured
DPP-4 Inhibitors and Incidence of Inflammatory Bowel Disease in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dipeptidyl Peptidase-4 Inhibitors and Incidence of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: Population Based Cohort Study
BMJ 2018 Mar 21;360(xx)k872, D Abrahami, A Douros, H Yin, OHY Yu, C Renoux, A Bitton, L AzoulayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.